Coronavirus

Adam Martin, PharmD, founder of the Fit Pharmacist, discusses tips for staying hopeful and motivated.

Many health care companies are taking the opportunity to deliver testing kits to local pharmacies to properly equip pharmacists with the right resources during the pandemic.

A new study found that alternative swab materials and commonly available saline are effective for COVID-19 testing, allowing patients to self-administer tests.

New research has found that hospitalized patients with COVID-19, diabetes, and/or uncontrolled hyperglycemia have significantly higher mortality rates.

Loss of smell and taste has been anecdotally linked to COVID-19 infections, according to a study that reported the first empirical findings that strongly associate sensory loss with coronavirus disease 2019.

Pharmacists have the opportunity during the COVID-19 outbreak to show who we really are.

Brooke Griffin, PharmD, BCACP, discusses the 21st Century PharmD and how students are responding to COVID-19.

N95 respirators can be decontaminated effectively and maintain functional integrity for up to 3 uses, according to a study by the National Institutes of Health (NIH).

The CDC's updated guidance for pharmacies during the COVID-19 pandemic is based on the most recent information regarding safety practices and precautions for the disease.

As demands for pharmacy services increase, including COVID-19 point-of-care testing, pharmacy technician roles must continue to evolve to fill gaps in care and shortages of labor capital.

A survey conducted between March 30 to April 6 by InsightRx found that implementing the new vancomycin guidelines into the pharmacy community is as important as the coronavirus disease 2019 (COVID-19) in the healthcare system.

The clinical practice update incorporates emerging evidence and available guidance for patients with IBD.

Today, we’re thanking Luke Morrison, MHA, operations manager at Gates Pharmacy in North Carolina.

Located in Chapel Hill, North Carolina, the organization hopes to raise $125 million to generate 5 new drugs with human safety and dosing data in 5 years to be ready for the next pandemic.

The antiviral drug remdesivir has been shown by researchers to effectively stop the replication mechanism of SARS-CoV-2 that causes COVID-19, according to a new study.

Today, we’re thanking Jessica Tackett, PharmD, BCPS, and Brittany Bissell, PharmD, PhD, BCCCP, both of whom work in the University of Kentucky (UK) HealthCare system.

Patients with lupus are experiencing difficulties in accessing medications hydroxychloroquine and chloroquine, 2 medications currently being investigated as potential treatment for the coronavirus 2019 disease.

Parata Systems has launched the Pharmacy Employee Relief Fund with an initial commitment of $100,000 to support employees of retail, long-term care, hospital, and direct-to-home pharmacies across the United States affected by the coronavirus disease 2019.

The widely available anti-parasitic drug ivermectin is capable of killing COVID-19 within 48 hours in a cell culture, according to a new study.

Additionally, blood group O has a significantly lower risk for the infection compared with non-O blood groups, according to the researchers.

Public policies to increase compliance with community mitigation strategies may be effective in decreasing community mobility.

Today we’re thanking Andrea and Ann-Marie Idusuyi, 2 sisters working hard on the frontlines of the COVID-19 pandemic.

Remdesivir is not yet licensed or approved anywhere internationally and has not been demonstrated to be safe or effective for the treatment of COVID-19.

Researchers investigated the presence of coronaviruses in the bat population due to an understanding that coronaviruses can spread following a spillover from animals.

Chloroquine, hydroxychloroquine, and azithromycin are currently being evaluated as potential treatments for COVID-19, despite limited evidence to support the drugs’ efficacy.

The American Lung Association (ALA) has started a $25M initiative to address the coronavirus disease 2019 (COVID-19) pandemic and other future respiratory virus pandemics.

A study based in Brazil has been halted early for safety reasons after patients with coronavirus disease 2019 taking a higher dose of chloroquine developed irregular heart rates that increased their risk of a potentially fatal heart arrhythmia.

A new test developed for the coronavirus disease 2019 (COVID-19) that uses saliva has been approved by the FDA, according to Rutgers University.

Providers with access to COVID-19 tests have reported false-negative results for some patients, raising concerns about the limitations of tests as a source of reliable information.

Although chloroquine and hydroxychloroquine have been touted as potential treatments for COVID-19, physicians in Italy have warned that the global supply may not be able to keep up with demand.